Pharmaceutical treatment of osteoarthritis.

Richard, M J; Driban, J B; McAlindon, T E

Richard, M J; Driban, J B; McAlindon, T E.

Affiliation

Richard MJ; Division of Rheumatology, Immunology, and Allergy, Tufts Medical Center, Boston, MA, USA. Electronic address: mrichard1@tuftsmedicalcenter.org.
Driban JB; Division of Rheumatology, Immunology, and Allergy, Tufts Medical Center, Boston, MA, USA. Electronic address: jdriban@tuftsmedicalcenter.org.
McAlindon TE; Division of Rheumatology, Immunology, and Allergy, Tufts Medical Center, Boston, MA, USA. Electronic address: tmcalindon@tuftsmedicalcenter.org.

Osteoarthritis Cartilage ; 31(4): 458-466, 2023 04.

Article in En | MEDLINE | ID: mdl-36414224

Subject(s)

Osteoarthritis, Knee; Tramadol; Humans; Osteoarthritis, Knee/drug therapy; Acetaminophen/therapeutic use; Tramadol/therapeutic use; Capsaicin/therapeutic use; Cyclooxygenase 2 Inhibitors/therapeutic use; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Pharmaceutical Preparations

Key words

Osteoarthritis; Pain management; Pharmaceutical; Pharmacological; Practice guideline

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tramadol / Osteoarthritis, Knee Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Osteoarthritis Cartilage Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google